DEUBIQUITINASES IN HEMATOLOGICAL MALIGNANCIES

Deubiquitinases in hematological malignancies

Abstract Deubiquitinases (DUBs) are enzymes that control the stability, interactions or localization of most cellular proteins by removing their ubiquitin modification.In recent years, some DUBs, such as USP7, USP9X and C-Safe Board USP10, have been identified as promising therapeutic targets in hematological malignancies.Importantly, some potent i

read more


Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice.

Studies of homozygous PAR2 gene knockout mice have described a mix of phenotypic effects in vitro and in vivo.However, there have been few studies of PAR2 heterozygous (wild-type/knockout; PAR2-HET) mice.The phenotypes of many hemi and heterozygous transgenic mice have been described as intermediates between those of wild-type and knockout Bachelor

read more